Major drug makers are looking for products by purchasing smaller companies, creating many value opportunities, Barron's reported in its Jan. 31 edition.
Among the companies that Barron's singled out were Acorda, AMAG Pharmaceuticals, Alexion, BioMarin, Cadence, Cephalon, Cubist , Dendreon, Human Genome, Jazz Pharma , Onyx, United Therapeutics, and Salix Pharmaceuticals.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
Compelling solutions through strategic partnerships
Ineos CEO Ineos calls on European politicians to save the chemical industry.
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
